- Patent Title: Systems and methods for subretinal delivery of therapeutic agents
-
Application No.: US14132859Application Date: 2013-12-18
-
Publication No.: US10010447B2Publication Date: 2018-07-03
- Inventor: Pooria S. Kashani , Michael Papac
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Main IPC: A61F9/00
- IPC: A61F9/00 ; A61M5/178 ; A61M5/32 ; A61B17/00

Abstract:
A retinal treatment system for delivering therapeutic agents to a target location with a retina is disclosed herein. The retinal treatment system includes a console having a control system and a handheld device coupled to the control system. The handheld device includes an inner tube disposed within an outer tube and being axially moveable within the outer tube. The inner tube has a perforating tip that is configured to perforate an inner limiting membrane of the retina. The handheld device further includes a chamber coupled to a proximal end of the inner tube that is configured to receive a fluid containing therapeutic agents injectable from the perforating tip. The control system of the retinal treatment system permits a user to maintain a position of the handheld device relative to the retina and activate an injection of a portion of the fluid through the inner tube into the retina.
Public/Granted literature
- US20150164687A1 Systems and Methods for Subretinal Delivery of Therapeutic Agents Public/Granted day:2015-06-18
Information query